This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SunLink Health Systems, Inc. Announces Fiscal 2011 Fourth Quarter And Full-Year Results

Stocks in this article: SSY

SunLink Health Systems, Inc. (NYSE Amex Equities: SSY) today announced a loss from continuing operations for its fourth fiscal quarter ended June 30, 2011 of $388,000 excluding pre-tax impairment charges of $13,347,000 to write down goodwill and certain intangible assets acquired in the April 2008 acquisition of Carmichael’s Cashway Pharmacy.

For the fourth fiscal quarter ended June 30, 2011, SunLink reported a loss from continuing operations of $8,703,000 or a loss of $1.07 per fully diluted share (after impairment charges), compared to a loss from continuing operations of $1,549,000, or a loss of $0.19 per fully diluted share (after impairment charges), for the quarter ended June 30, 2010.

SunLink reported a net loss of $8,864,000, or a loss of $1.09 per fully diluted share (after impairment charges), for the quarter ended June 30, 2011, compared to a net loss of $1,516,000, or $0.19 per fully diluted share (after impairment charges), for the comparable quarter a year ago. Excluding impairment charges for goodwill and certain intangible assets of Carmichael’s Cashway Pharmacy, the net loss for the quarter ended June 30, 2011 would have been $549,000, and excluding impairment charges, the net loss for the quarter ended June 30, 2010 would have been $767,000.

Consolidated net revenues from continuing operations for the quarters ended June 30, 2011 and 2010 were $43,214,000 and $43,615,000, respectively, a decrease of 0.9% in the current year’s quarter. The Healthcare Facilities Segment net revenues in the current quarter of $36,369,000 increased $1,532,000, or 4.4%, compared to $34,837,000 from the prior year. The Specialty Pharmacy Segment revenues of $6,845,000 in the quarter ended June 30, 2011 decreased 22.0% from the prior year.

The company had an operating loss from continuing operations, which included charges of $13,347,000 for impairment of goodwill and certain intangible assets of Carmichael’s Cashway Pharmacy, for the quarter ended June 30, 2011 of $12,477,000, compared to an operating loss for continuing operations for the quarter ended June 30, 2010 of $2,119,000, which included $1,202,000 impairment of construction in progress. Excluding the impairment charges for both periods, the operating margin increased by $1,787,000 due to the $4,116,000 in net revenues from the Medicare and certain Medicaid EHR Incentive Programs in the current year. Adjusted EBITDA (a non-GAAP measure of the liquidity of the company) at SunLink’s Healthcare Facilities Segment in the fourth fiscal quarter increased to $4,073,000 from $2,174,000 in the comparable quarter a year ago. Adjusted EBITDA for SunLink’s Specialty Pharmacy Segment was a loss of $377,000 in the fourth fiscal quarter compared to Adjusted EBITDA loss of $12,000 in the comparable quarter a year ago.

1 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs